-
DR Horton
$DHI offering up a pullback opportunity printing a bullish engulfing bar after retracing some of its January rally. One of four swing trade setups from our video today. More here: https://www.thetraderisk.com/stock-market-swing-trade-ideas-2-5-20/?utm_medium=social&utm_source=twitandtweet&utm_campaign=tradeideasvideo … including setups in$PFSI$ARVN and$ALNY#Stocks#Tradingpic.twitter.com/1fs4Lpw5oH
-
$ALNY reports before the open tomorrow, Estimize Consensus +0.20 EPS and +3.78M Revs compared to WS - http://www.estimize.com/alny/fq4-2019?utm_content=prerelease&utm_medium=tweet&utm_source=twitter … -
$ALNY is above its desc rl -
$NSPX 0038 THE MONSTER AWAKENING WATCHING?! cancer#BIOTECH use ur eyes
$CLLS$SRNE$KOOL$ZIOP$MDT$ABT$EW$BIO$TNDM$PODD$OSUR$MYL$EGRX$ANIP$COLL$LCI$PRGO$ENDP$ONCE$SGMO$AMGN$BIIB$GILD$ALNY$ALKS$BLUE$CELG$TSRO$BMRN$PBYI$NTLA$EDIT$CRSP$XON$GBT$IONSpic.twitter.com/V8dFpEAOza -
-
$ARWR newly issued U.S. Patent No. 10,550,391 today for "Organic Compositions to Treat Beta-ENaC-Related Diseases." Former$NVS &$ALNY IP acquired by@ArrowheadPharma. Treats:#CysticFibrosis#PHA1#LiddlesSyndrome#Hypertension#Alkalosis#Hypokalemia. http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=10550391.PN.&OS=PN/10550391&RS=PN/10550391 … -
$ALNY option volume was 3X normal on Friday with 2,995 contracts. Call volume was 89% and put volume was 11%. https://marketchameleon.com/Overview/ALNY/OptionChainPro/?e=225_20200221 … -
Information from NASDAQ,
$ALNY will report an outline of the 2019 performance on 6th Feb, 2020. -
Squeeze play pattern detected by our stock screener for
$REGI,$SXTC and$ALNY. https://www.chartmill.com/stock/stock-screener?sid=12&f=sqds,v1_50b300,sl_ti_105_X,exch_us&v=3&timeframe=DAILY&type=CANDLES&months=0.05&width=400&cl=F&o1=0&o2=57&op1=14&op2=20,1.5,10&utm_source=twitterUS&utm_medium=screener&utm_content=Stock_Screener:_Momentum_Squeeze_Play_Setups&utm_campaign=social_tracking … -
$ALNY,$NCR and$EVOK are showing a squeeze play pattern today. They could be ready for breakout. https://www.chartmill.com/stock/stock-screener?sid=12&f=sqds,v1_50b300,sl_ti_105_X,exch_us&v=3&timeframe=DAILY&type=CANDLES&months=0.05&width=400&cl=F&o1=0&o2=57&op1=14&op2=20,1.5,10&utm_source=twitterUS&utm_medium=screener&utm_content=Stock_Screener:_Momentum_Squeeze_Play_Setups&utm_campaign=social_tracking … -
$ARWR newly issued U.S. Patent No. 10,544,418 today for "RNAi Inhibition of Alpha-ENaC Expression." Formerly owned by$NVS &$ALNY - acquired by$ARWR in$NVS IP acquisition in 2015.#CysticFibrosis#RNAi#biotech#GameOn http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=10,544,418.PN.&OS=PN/10,544,418&RS=PN/10,544,418 … -
"It would shock me if anybody could write a big enough check to make sense to our shareholders," Arrowhead's CEO told me. Read my latest on the exploding RNAi space of
$ARWR$ALNY and$DRNA:https://bit.ly/3al9Zcz -
$ALNY takes next step toward meeting goal of having 4 approved drugs by YE 20, starts rolling BLA for lumasiran to treat a form of hyperoxaluria https://www.businesswire.com/news/home/20200110005467/en/Alnylam-Initiates-Rolling-Submission-New-Drug-Application … The RNAi therapeutic met the primary endpt in a Ph 3 last month:https://www.biocentury.com/bc-extra/clinical-news/2019-12-17/alnylam%E2%80%99s-lumasiran-latest-rnai-therapeutic-hit-pivotal-study-goal …
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
